Inventor · disambiguated record
Fabian Wirth
Also filed as: WIRTH FABIAN
1 granted patent·2 pending applications·0 citations·filing 2015–2022
14Inventor score
Technology areasC07K
Files withNEURIMMUNE HOLDING AG3
Top patents by PatentIndex Score
3 records- 0169US2023287106A1Novel compounds capable of antagonizing islet amyloid polypeptide (iapp) induced beta-cell damage and impaired glucose toleranceNEURIMMUNE HOLDING AG·Filed 2022·Application pending·0 cites
- 0260US2020231667A1Novel compounds capable of antagonizing islet amyloid polypeptide (iapp) induced beta-cell damage and impaired glucose toleranceNEURIMMUNE HOLDING AG·Filed 2019·Application pending·0 cites
- 0352US10544213B2Compounds capable of antagonizing islet amyloid polypeptide (IAPP) induced beta-cell damage and impaired glucose toleranceNEURIMMUNE HOLDING AG·Filed 2015·Granted Jan 28, 2020·0 cites·24 claims
Join the waitlist — get patent alerts
Get an alert when Fabian Wirth files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →